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ABSTRACT 
Tissue engineering and regenerative medicine are increasingly taking advantage of active 
materials, allowing to provide specific clues to the cells. In particular, the use of electroactive 
polymers that deliver an electrical signal to the cells upon mechanical solicitation, open new 
scientific and technological opportunities, as they in fact mimic signals and effects that occur 
in living tissues, allowing the development of suitable microenvironments for tissue 
regeneration. Thus, a novel overall strategy for bone and muscle tissue engineering was 
developed based on the fact that these cells type are subjected to mechano-electrical stimuli in 
their in vivo microenvironment and that piezo- and magnetoelectric polymers, used as 
scaffolds, are suitable for delivering those cues. The processing and functional 
characterizations of piezoelectric and magnetoelectric polymers based on poly(vinylindene 
fluoride) and poly-L-lactic acid in a variety of shapes, from microspheres to electrospun mats 
and three dimensional scaffolds, are shown as well as their performance in the development 
of novel bone and muscle tissue engineering. 
INTRODUCTION 
Piezoelectric polymers have already shown strong potential for novel tissue 
engineering (TE) strategies, once they can account for the existence of piezoelectricity 
within some specific tissues, indicating their requirement also during tissue regeneration 
[1]. Further, they can modulate the electrical signals existing during tissue development 
and function. Still, in some cases, the patient is immobilized, and as a result the natural 
mechanical stimulus does not occur [2]. Such limitation points to the 
development of new materials able to remotely mechanical and/or electrically stimulate 
tissues from outside of the human body and/or during in vitro cell culture to explore 
specific differentiation paths. Magnetoelectric (ME) composite materials provide such an 
innovative tool, allowing the use of an external magnetic field to remotely control tissue 
stimulation, without the need of patient movement. Those composites are composed of 
magnetostrictive and piezoelectric materials, resulting in the ME effect [3]. 
Moreover, for TE, the design of the scaffolds influence the transmission of 
biochemical, morphological, electrical and mechanical signals defining the ultimate 
shape of the newly grown soft or hard tissue [1].  
In this way, new paradigms for TE also include the need of active/smart 
biomaterials with appropriate forms and geometries in order to properly regenerate 
specific tissues. The electromechanical stimulation can be effectively conducted by 
piezoelectric polymers, such as poly(vinylidene fluoride) (PVDF), a semi-crystalline 
polymer that has four differentiated crystalline phases (α, β, γ, δ), being the β-phase the 
one with the highest piezoelectric coefficient [1]. However, PVDF polymer is non-
degradable, and for approaches where biodegradability is required, poly(L-lactic acid) 
(PLLA), with lower piezoelectric response, can be employed. 
PIEZO- AND MAGNETOELECTRIC BIOMATERIALS AND STRUCTURES 
Electroactive polymers such as PVDF and PLLA have been processed into 
scaffolds with various morphologies and dimensionalities, including microspheres [4-5], 
membranes [6-8], fibers [9-11], and three dimensional (3D) scaffolds by different 
methods [12] such as electrospray, solvent casting and electrospinning methods 
(figure 1). Recently, efforts are being focus in the development of magnetoelectric 
biomaterials through the incorporation of magnetic particles for TE [13]. Scaffolds based 
on microspheres have received increasing attention for biomedical applications and 
support for cell expansion and differentiation [4, 14]. Piezo- and magnetoelectric 
microspheres can be produced by different methods such as phase separation or 
precipitation, emulsion/solvent evaporation and electrospray [4]. The variation of the 
processing parameters generally allows the control of the particle size and size 
distribution. PVDF microspheres with a smooth surface and an average diameter 
between 800 nm up to 7 μm have been obtained by electrospray method, where 
microspheres are produced using a polymer solution in a sufficiently conductive solvent 
[4, 15]. During the electrospray method, depending on the solution parameters (including 
solution concentration, viscosity and surface tension) and the processing parameters 
(flow rate, needle diameter, distance of needle to collector, and applied voltage), a 
continuous and charged jet can be broken down into droplets, resulting in microspheres 
of different size [16]. This method may overcome the drawbacks associated with 
conventional particle-producing methods such as solvent casting, single and double 
emulsion, spray-drying, porous glass membrane emulsification, and coacervation [16]. 
Few studies have been reported on PVDF and PLLA magnetoelectric microspheres. 
Magnetoelectric PVDF microspheres obtained by this method embedded 
magnetostrictive particles such as cobalt ferrites (CoFe2O4) nanoparticles into the PVDF 
sphere matrix are mainly in the β-phase (between 65% and 85%) [15]. It is worth 
noticing that electrospray does not allow an accurate control of the sphere size [17]. 
From an emulsion-solvent extraction/evaporation method it is possible obtain 
biodegradable piezo- and CoFe2O4 composite PLLA-based microspheres with 
controllable size and diameters ranging between 0.16 and 3.9 µm for neat PLLA and 
between 0.8 and 2.2 µm for the composite microspheres [17]. Particularly for neural and 
muscle applications, TE fibrous scaffolds have been designed to support and guide the 
longitudinal cells extension along their natural axis of growth [18]. Oriented and random 
electrospun fibers with small pore size, 
density and high surface area can be 
obtained by electrospinning, similarly 
to the electrospray method, when 
solution viscosity is high enough (in 
the range of 650–2500 cP) [19]. The 
electrospinning process allows to 
effectively obtain PVDF and PLLA 
random and oriented fibers using a 
static and a rotating collector, 
respectively, with average diameters 
ranging from ~500-900 nm [11, 20]. 
According to [11], PVDF random 
electrospun fibers show a  phase 
content around 50%. Increasing the 
rotation speed of the collector from 
500 to 2000 rpm, the fraction of β 
phase increases and may range 
between 50 to 85 % due to the higher 
stretching of the jet during the 
electrospinning process. Furthermore, 
the introduction of magnetostrictive 
nanoparticles into the polymeric PVDF 
solution allows the processing of 
magnetoelectric fibers with an average fiber diameter of ~325 nm [21]. According to 
[22], depending on solvent and electrospun processing parameters, it is possible to adjust 
the dominant crystalline phase producing fibers mainly containing α or trans-state (β or γ 
phases). The crystallization process of PVDF predominantly in the β phase can be 
obtained using high voltage or high stretching ratio of the jets and a rotating collector. 
Further, the processing conditions and solvent used influence the crystalline fraction and 
other characteristics such as fiber average diameter, specific surface area, surface tension 
and mechanical properties [11, 22].  
Three dimensional porous scaffolds have been obtained by solvent casting/salt 
leaching, phase separation, gas foaming, gel casting, precipitation and emulsion freeze–
drying [12]. The main advantages of these pore interconnected scaffolds are related with 
their ability to promote better interaction between cells and tissues, transport of 
metabolite and nutrients and an appropriate transmission of biochemical/mechanical and 
or electrical cues leading to the stimulation of both cells and tissues [12]. Electroactive β-
PVDF 3D scaffolds with different porous sizes, architectures and pore interconnectivity 
have been obtained by solvent casting/particulate leaching (300 to 400 μm) and using a 
nylon template (~60 μm or ~150 μm). Also, freeze extraction methods with a PVA 
template promotes the formation of porous scaffolds with averages diameters of ~300 
and 500 μm, being the porous average diameters in the same range of the sacrificial 
material. Thus, the variation of the ratio of the salt into the solution and the distance of 
the filaments of the template allow to control the pore size of the scaffold [12]. A similar 
procedure, including liquid-liquid phase separation with freeze extraction is employed to 
process PLLA scaffolds with interconnected pores with pore size ranging from 20 to 
60 µm [23]. 
Figure 1. a)Neat and b) magnetic PLLA microspheres 
obtained by an oil-in-water emulsion; c) random and d) 
oriented PLLA fibers obtained by electrospinning; PVDF 3D 
scaffolds obtained by e)solvent casting/NaCl particulate 
leaching, f) solvent casting and nylon template and g) freeze 
extraction. 
TISSUE ENGINEERING BASED ON PIEZO- AND MAGNETOELECTRIC 
BIOMATERIALS 
Active polymers have been used in several TE applications such as bone, neural 
and muscle tissues [24]. In particular, piezoelectric and magnetoelectric polymers have 
been used in different morphologies and with different cell type. However, most of these 
studies were performed in static conditions. The piezoelectric and magnetoelectric effect 
is only proven when the dynamic conditions (either mechanical or electrical) are applied 
(Table 1), otherwise, just the suitability of the materials and the significance of the 
surface charge, when the material is poled, are demonstrated [1].  
PVDF and its copolymers are the piezoelectric polymer most used for TE 
applications due to their larger piezoelectric response [19]. In particular, most of the 
studies describing cell response under dynamic stimulation use PVDF as a support for 
the cell proliferation and differentiation. Rodrigues et al. showed that -PVDF positively 
charged films provide an adequate environment for enhancing the growth and 
differentiation of goat marrow cells into osteoblast in dynamic conditions, exhibiting an 
ideal support for the seeding and the development of undifferentiated cells towards a 
desired phenotype [25]. The combination of biochemical and physical stimuli can lead to 
a successful approach of a biomimetic microenvironment present in the human body. 
Ribeiro et al. showed that PVDF negatively charged films [26] under dynamic 
conditions, more properly mechanical stimulation, lead to enhanced osteogenic 
differentiation of human adipose stem cells, which was confirmed by higher alkaline 
phosphatase activity [27]. In the presence of PVDF films, MC3T3-E1 pre-osteoblast cells 
showed different responses. In the presence of positively charged -PVDF films and in 
mechanical stimuli, a higher osteoblast adhesion and proliferation was observed [28]. 
These results were confirmed with in vivo studies where -PVDF films were implanted 
in a bone defect, demonstrating significantly more defect closure and bone remodeling. 
In this case, the mechanical solicitations are obtained by the rat movements [29]. Other 
piezoelectric polymers have also been used such as collagen type I where the studies 
demonstrated that the 3D samples mechanically stretched promote the proliferation and 
differentiation of human osteoblastic precursor cells due to the increase of genes 
expression related to the early and late stages of osteoblastic differentiation [30]. 
Relatively to nerve regeneration, it has also been shown that PVDF and 
poly(vinylidene fluoride-trifluoroethylene) (PVDF-TrFe) under dynamic conditions 
promote cell proliferation and differentiation. Previous studies reported by [31] 
demonstrated that poled PVDF increases the percentage of differentiated neurons of 
mouse neuroblastoma cells and respective neurite lengths after 96 h of cell culture with 
both media conditions. These results have been also verified with PVDF-TrFe [31]. 
Composites are also used. Thus, nerve stem cells cultured on PLLA nanofibers with 
PANI resulted in an extended neurite outgrowth when electrically stimulated when 
compared to the cells grown on non-stimulated scaffolds [18]. 
Guo et al. reported that polyurethane/poly(vinylidene fluoride) (PU/PVDF) 
prepared by electrospinning have an influence on wound healing. When the cells were 
excited by piezoelectric effect, the adhesion of the fibroblasts (NIH3T3) was enhanced 
and consequently, higher mRNA and protein expression levels than the control scaffolds 
were shown [32]. 
A novel approach for TE applications has been achieved with biomaterials with 
magnetoelectric response. The studies were realized with MC3T3-E1 pre-osteoblast cells 
and magnetoelectric Terfenol-D/PVDF-TrFe composites. These biomaterials promote 
≈25% of cell proliferation when the cells are cultured under mechanical and electrical 
stimulation remotely triggered by the application of a varying magnetic field [17]. 
For muscle regeneration, it was already proven that the surface charged 
enhanced the cell proliferation [33]. However, until now, the study under dynamic 
conditions with piezoelectric biomaterials has not yet been performed. 
Table 1 - Biomaterial, cell culture condition and cells used for different applications. 
Biomaterial Conditions Cells Application Ref. 
PVDF 
positively 
poled  
-Mechanical stimulation Goat marrow 
Bone 
[25] 
-Mechanical stimulation in vertical vibration  
-Frequency = 1Hz 
-Amplitude ≈1mm
MC3T3-E1 
pre-osteoblast 
[28] 
PVDF 
negatively 
poled  
-Mechanical stimulation in vertical vibration 
-Frequency = 1 Hz  
-Maximum amplitude ≈1mm
Human 
adipose stem 
[27]
Terfenol-
D/P(VDF-
TrFE) 
-Magnetic stimulation;  
-Active time = 16 h (10 min of active time and 
20 min of repose time); 
-Non-active time = 8 h; 
-Frequency = 0.3 Hz; 
-Displacement of permanent magnets ≈ 20 mm; 
-Maximum value = 230 Oe;  
-ME voltages = 0.115 mV.  
MC3T3-E1 
pre-osteoblast 
[17] 
Colagen type I 
-Stretched cyclically along the long axis  
-Frequency = 1 Hz 
-Magnitude = 10,000 μstrain (1%) 
-Number of cycles = 1800 
-Time = every day for 30 min over a period of 3 
weeks.
Human 
osteoblastic 
precursor 
[30] 
PVDF and 
PVDF-TrFe 
-Sinusoidal output (vibrational forces); 
-Peak voltage ≈ 2.5mV;  
-Frequency = 1200Hz 
-Standard incubator shelves
Mouse 
neuroblastoma 
Nerve 
[31] 
PLLA/PANI 
-A silver electrode and a platinum electrode were 
inserted to opposite ends of the nanofibrous 
scaffold;  
-Constant voltage = 1.5 V; 
-Time = 60 min; 
-Electric field = 100 mV/mm.
Nerve stem 
cells 
[18] 
PU/PVDF 
-Intermittent deformation of 8% 
-Frequency = 0,5 Hz
NIH3T3 
Wound 
healing 
[32] 
CONCLUSIONS 
The abovementioned studies indicate the relevance of the use of piezo- and 
magnetoelectric biomaterials for tissue engineering applications, allowing the 
development of a novel biomimetic approach, where electrical and/or electromechanical 
stimuli is required for proper cell/tissue development.  
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